Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway
Histone deacetylase (HDAC) expression and enzymatic activity are dysregulated in cardiovascular diseases. Among Class I HDACs, HDAC2 has been reported to play a key role in cardiac hypertrophy; however, the exact function of HDAC8 remains unknown. Here we investigated the role of HDAC8 in cardiac hy...
Saved in:
Main Authors: | Tingwei Zhao (Author), Hae Jin Kee (Author), Liyan Bai (Author), Moon-Ki Kim (Author), Seung-Jung Kee (Author), Myung Ho Jeong (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HDAC Inhibition Suppresses Cardiac Hypertrophy and Fibrosis in DOCA-Salt Hypertensive Rats via Regulation of HDAC6/HDAC8 Enzyme Activity
by: Hae Jin Kee, et al.
Published: (2013) -
Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice
by: Hae Jin Kee, et al.
Published: (2019) -
Inhibition of HDAC6 alleviating lipopolysaccharide-induced p38MAPK phosphorylation and neuroinflammation in mice
by: Yuanjian Song, et al.
Published: (2019) -
Beyond β-Blockade: ACE Inhibitors Reduce Non-Cardiac Mortality in High Killip Grade AMI Patients
by: Simei Sun PhD, et al.
Published: (2024) -
TAZ stimulates exercise‐induced muscle satellite cell activation via Pard3-p38 MAPK-TAZ signalling axis
by: Kyung Min Kim, et al.
Published: (2023)